<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">STANOZOLOL</span><br/>(stan-oh'zoe-lole)<br/><span class="topboxtradename">Winstrol<br/></span><b>Classifications:</b> <span class="classification">hormones and synthetic substitutes</span>; <span class="classification">androgen/anabolic steroid</span><br/><b>Prototype: </b>Testosterone<br/><b>Pregnancy Category: </b>X<br/><b>Controlled Substance: </b>Schedule III<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>2 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Synthetic steroid with relatively strong anabolic and weak androgenic activity, similar to those for testosterone.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Increases protein metabolism and decreases catabolism through anabolic action. Can cause testicular atrophy. Androgenic activity
         controls secondary sex characteristics, adolescent growth spurts, as well as stimulation of renal production of erythropoietin.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Primarily to increase hemoglobin in selected cases of aplastic anemia, prophylaxis to decrease the frequency and severity
         of hereditary angioedema.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Male patients with carcinoma of the breast or with known or suspected carcinoma of the prostate; carcinoma of the breast in
         females with hypercalcemia; androgenic anabolic steroids may stimulate osteolytic resorption of bone; nephrosis, or the nephrotic
         phase of nephritis; pregnancy (category X)use may be fatal; lactation.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Diabetic patients; bleeding disorders, concurrent administration of anticoagulants; hepatic impairment; hypercholesterolemia.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Anemia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 2 mg t.i.d.; <i>young women,</i> 2 mg 12 times/d<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 6 y, 1 mg b.i.d.; <i>612 y,</i> 2 mg t.i.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give just before or with meals to reduce incidence of gastric distress.</li>
<li> 				Note: Smaller dose for young women is given to prevent virilizing effects of the drug. Notify physician if such effects appear (early
            sign: change of voice). 			
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Excitation, insomnia. <span class="typehead">CV:</span> Skin flushing and vascularization. <span class="typehead">GI:</span> Nausea, vomiting, anorexia, diarrhea, gastric pain, jaundice. <span class="typehead">Hematologic:</span> Leukopenia. <span class="typehead">Metabolic:</span> Hypercalcemia, hypercholesterolemia, <span class="speceff-common">sodium and water retention (especially in older adults) with edema.</span> <span class="typehead">Renal:</span> Renal calculi (especially in the immobilized patient), bladder irritability. <span class="typehead">Urogenital:</span> <span class="speceff-common">Increased libido.</span> <span class="typehead">Skin:</span> <span class="speceff-common">Acne</span>, injection site irritation and sloughing. <span class="typehead">Body as a Whole:</span> Hypersensitivity to testosterone, <span class="speceff-life">anaphylactoid reactions</span> (rare). <span class="typehead">Hematologic:</span> precipitation of acute intermittent porphyria. <span class="typehead">Endocrine:</span> FemaleSuppression of ovulation, lactation, or menstruation; hoarseness or deepening of voice (often irreversible); hirsutism;
      oily skin; clitoral enlargement; regression of breasts; male-pattern baldness (in disseminated breast cancer); flushing, sweating;
      vaginitis with pruritus, drying, bleeding; menstrual irregularities. Male<span class="speceff-common">Prepubertal:</span> premature epiphyseal closure, phallic enlargement, priapism. <span class="speceff-common">Postpubertal:</span> Testicular atrophy, decreased ejaculatory volume, azoospermia, oligospermia (after prolonged administration or excessive
      dosage), impotence, epididymitis, priapism, <span class="speceff-common">gynecomastia</span>. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> Prolongs action of <b>succinylcholine</b> and possibly other <span class="classification">neuromuscular blocking agents</span> due to inhibition of plasma pseudocholinesterase. Increases <b>theophylline</b> concentrations twofold. <b>Cimetidine</b> increases concentration of <b>tacrine</b> by 64%. May deplete <b>iron</b> stores; may increase risk of bleeding with <span class="classification">oral anticoagulants</span>. <span class="typehead">Herbal:</span> <b>Echinacea</b> may increase risk of hepatotoxicity. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Metabolism:</span> Metabolized in liver. See testosterone. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Monitor Hct and Hgb periodically to determine efficacy of drug. Periodic serum electrolytes and lipid profile.</li>
<li>Check with physician concerning restricted salt intake.</li>
<li>Be alert to symptoms of hypercalcemia (see Appendix F).</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Use with high-calorie, high-protein diet unless contraindicated.</li>
<li>Drug does not enhance athletic ability.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>